- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05970939
Development, Reliability and Validity of the Telerehabilitation Usability Questionnaire- TrUQ
November 13, 2024 updated by: Kader Eldemir, Gazi University
Development, Reliability and Validity of the Telerehabilitation Usability Questionnaire- TrUQ in Neurological Diseases
Neurological diseases are central nervous system diseases that cause an increase in the level of disability and limitations in daily life.
Multiple Sclerosis (MS), stroke, and Parkinson's Disease (PD) are among the most common apparent neurological diseases, and epidemiological studies show that their prevalence has increased over time worldwide.
Although MS, stroke, and PD have different causes and neurological aspects, they generally cause motor, sensory, and/or cognitive impairments, leading to restriction of the individual's activities and participation.
Today, physiotherapy and rehabilitation approaches together with optimal medical and surgical treatment are the cornerstones of treatment for these diseases.
Recently, it has been stated that various telerehabilitation interventions in the field of physiotherapy and rehabilitation may be an additional option to the rehabilitation approaches applied in the clinic.
On the other hand, It is important to evaluate the level of usability in expanding the usability of telerehabilitation services and determining the best telerehabilitation service.
For this reason, there is a need for questionnaires investigating the satisfaction level of physiotherapy and rehabilitation applied through telerehabilitation.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Questionnaire items will be created in two stages.
First, 5 experts will independently review the literature on "telerehabilitation" and "usability".
In addition, these experts will be asked to create a pool of questions based on their experiences in telerehabilitation and by taking the opinions of patients receiving telerehabilitation about usability.
Then, 5 experts will come together and obtain a single question pool containing the questions they deem important in their question pool.
The second step will involve scaling the elements.
In this study, scale items will be scored on a five-point Likert scale, ranging from 1, strongly disagree to 5, strongly agree.
Then, it will be applied to a pilot group of 10 people and it will be evaluated whether the items prepared by the experts are understood by the patients.
In line with the expert opinion and the result of the pilot study, the final version of the scale will be decided and applied to MS, PD, and stroke patients who make up the study group.
Finally, the validity and reliability of the questionnaire will be calculated.
Study Type
Observational
Enrollment (Actual)
95
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Ankara, Turkey
- Gazi University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
Neurological patients receiving physiotherapy and rehabilitation via telerehabilitation
Description
Inclusion Criteria:
- Voluntarily participate in research to accept
- Mini-Mental Test score more than or equal 24
- Previously receiving physical therapy through telerehabilitation
Exclusion Criteria:
- Any visual, hearing, and perception problems that may affect the answering the questionnaire items
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Telerehabilitation Usability
Telerehabilitation Usability Group
|
This study will be examined the development, validity, and reliability of the Telerehabilitation Usability Questionnaire in patients with MS.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Telerehabilitation Usability Questionnaire in patients with Neurological disease
Time Frame: Baseline
|
Patients get a minimum of 0 points (best condition) and a maximum of 4 points (worst condition) for each question on this scale
|
Baseline
|
|
Telerehabilitation Usability Questionnaire in patients with Neurological disease-Second
Time Frame: he second assessment will be conducted after the one week
|
Patients get a minimum of 0 points (best condition) and a maximum of 4 points (worst condition) for each question on this scale
|
he second assessment will be conducted after the one week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 28, 2023
Primary Completion (Actual)
October 28, 2024
Study Completion (Actual)
October 28, 2024
Study Registration Dates
First Submitted
July 24, 2023
First Submitted That Met QC Criteria
July 24, 2023
First Posted (Actual)
August 2, 2023
Study Record Updates
Last Update Posted (Estimated)
November 14, 2024
Last Update Submitted That Met QC Criteria
November 13, 2024
Last Verified
November 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ND-Development-TrUQ
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Neurological Disease
-
University of LeedsThe Royal College of Surgeons of EnglandCompletedSurgery | Surgery--Complications | Outcome, Fatal | Neurological Disorder | Morality | Neurological Morbidity | Neurological Complication | Comorbidities and Coexisting Conditions | Neurological Diseases or Conditions | Neurological Procedural Complication
-
Universidad Autonoma de San Luis PotosíUnknownNeurological DiseaseMexico
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingNeurological Diseases | Auto Immune Disease
-
FondationbHopaleGHICLRecruiting
-
University of North Carolina, Chapel HillCompleted
-
IRCCS Eugenio MedeaCompletedNeurological Diseases or ConditionsItaly
-
Neurogen Brain and Spine InstituteWithdrawn
-
Beth Israel Deaconess Medical CenterDartmouth CollegeCompletedNeuromuscular Disease Patients | Central Neurological Disease PatientsUnited States
-
Assistance Publique - Hôpitaux de ParisCompletedParaneoplastic Neurological SyndromesFrance
-
Centre Hospitalier Universitaire de la RéunionRecruitingNeurological ComplicationRéunion
Clinical Trials on Development of the Telerehabilitation Usability Questionnaire
-
Gazi UniversityCompletedNeurological DiseaseTurkey
-
Chang Gung Memorial HospitalCompleted
-
University Hospital TuebingenCompletedDepressive Disorder | Depression | Cognitive Impairment | Cognitive Dysfunction | Depression MildGermany
-
Federico II UniversityCompleted
-
Coloplast A/SCompletedQuality of Life | Nurse's Role | Colostomy Stoma | Stoma Ileostomy | Stoma Site LeakageDenmark
-
Hacettepe UniversityNot yet recruiting
-
University of HullBritish Dietetic AssociationCompleted
-
Istanbul UniversityRecruitingVirtual Reality | Duchenne Muscular Dystrophy (DMD)Turkey (Türkiye)
-
CHU de ReimsCompleted